Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period from May 1, 2018, to October 31, 2018, with a report date of November 27, 2018. The document serves as a Block Listing Six Monthly Return, detailing the status of unallotted securities under four specific employee share schemes.
Key Financial Metrics
The filing text does not provide revenue, profit, cash flow, margins, debt, or liquidity metrics. The document is strictly limited to reporting the movement of share reserves for employee compensation plans.
Material Changes in Share Schemes
- 2009 Deferred Annual Bonus Plan: The opening balance was restated due to a clerical error (from 33,863 to -27,669). The scheme was increased by 575,000 shares, with no shares issued during the period, resulting in an ending balance of 547,331.
- Share Option Plan - Ordinary Shares: The opening balance was restated due to a clerical error (from 2,693,951 to 2,755,483). No new shares were added to the block. 532,131 shares were issued/allotted, leaving an ending balance of 2,223,352.
- Share Option Plan - ADS: No restatements or increases occurred. 573,898 shares were issued/allotted, reducing the balance from 7,909,994 to 7,336,096.
- Share Save Plan 2012: The scheme was increased by 5,000,000 shares. 154,683 shares were issued/allotted, resulting in an ending balance of 5,672,623.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. The only unusual item noted is the clerical error requiring restatement of opening balances for two of the four schemes.
Investor Verification Checklist
- Verify the impact of the clerical errors on the historical reporting of the 2009 Deferred Annual Bonus Plan and the Ordinary Share Option Plan.
- Confirm the total number of shares issued under the Share Option Plans (Ordinary and ADS) and the Share Save Plan during the six-month period.
- Review the authorization for the 5,000,000 share increase in the Share Save Plan 2012 and the 575,000 share increase in the Deferred Annual Bonus Plan.